Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes

Table 2 Multivariate logistic analysis identifying independent predictors of pathological complete response

Factor	OR	95%CI	P value
Sex
Male vs female	1.76	0.74-4.18	0.201
NACT-Surgery interval time
< 4 wk vs > 6 wk	0.69	0.22-2.13	0.521
4-6 wk vs > 6 wk	0.26	0.07-0.96	0.044
Clinical T stage
T2 vs T4	1.99	0.70-5.68	0.200
T3 vs T4	2.90	1.04-8.01	0.041
Clinical N stage
Positive vs negative	2.12	0.90-4.97	0.086
Tumor diameter (before NACT)
≤ 2 cm vs ≥ 5 cm	1.60	0.44-5.80	0.472
2-5 cm vs ≥ 5 cm	1.58	0.60-4.14	0.354

NACT: Neoadjuvant chemotherapy.